HEALTHQUARTZ
Novo Nordisk's weight loss pill is hitting 3 million U.S. prescriptions — and most users had never tried one before
Novo Nordisk's Wegovy weight loss pill has reached 3 million U.S. prescriptions, with over 80% of new prescriptions issued to patients who had never previously taken a GLP-1 drug.
Related Signal
Adjacent reporting
- The Wegovy pill is still dominating the GLP-1 pill market
- Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history
- Healthy Returns: Novo Nordisk says high-dose Wegovy helped some patients lose nearly 28% of their weight
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- The next generation of Ozempic is here. Turbo shots deliver 250% more weight loss... at record speeds. Patients are begging for them - but there's a major warning: DR SHEILA NAZARIAN
- Novo Nordisk’s next obesity battlefront: Winning beyond America